|
GPBP1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.813600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.556040E-01 |
| Normal-vs-Stage2 |
1.769600E-01 |
| Normal-vs-Stage3 |
4.304100E-03 |
| Normal-vs-Stage4 |
6.121500E-03 |
| Stage1-vs-Stage2 |
7.735400E-01 |
| Stage1-vs-Stage3 |
2.974100E-02 |
| Stage1-vs-Stage4 |
5.699700E-02 |
| Stage2-vs-Stage3 |
2.363800E-01 |
| Stage2-vs-Stage4 |
2.807000E-01 |
| Stage3-vs-Stage4 |
9.543600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.387800E-02 |
| Normal-vs-AfricanAmerican |
4.083800E-01 |
| Normal-vs-Asian |
3.311400E-01 |
| Caucasian-vs-AfricanAmerican |
5.365600E-01 |
| Caucasian-vs-Asian |
3.541400E-01 |
| AfricanAmerican-vs-Asian |
9.486800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.463700E-02 |
| Normal-vs-Female |
6.839600E-02 |
| Male-vs-Female |
3.692800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.332000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.807800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.617960E-03 |
| Normal-vs-Age(81-100Yrs) |
1.850270E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.970000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.025900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.074630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.432760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.237600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.791800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.455700E-02 |
| Classical-VS-Follicular |
9.299800E-02 |
| Classical-VS-Other |
3.320400E-01 |
| Classical-VS-Normal |
2.071800E-01 |
| Tall-VS-Follicular |
7.036000E-01 |
| Tall-VS-Other |
9.530600E-01 |
| Tall-VS-Normal |
1.657860E-02 |
| Follicular-VS-Other |
8.374600E-01 |
| Follicular-VS-Normal |
2.551900E-02 |
| Other-VS-Normal |
1.595020E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.386100E-02 |
| Normal-vs-N1 |
7.175700E-03 |
| N0-vs-N1 |
3.393600E-01 |
|
|
